Patent · US Expired

Compositions for targeting the vasculature of solid tumors

US6051230A · kind A · utility

258Cited by
15References
61Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 1, 1995
Grant dateApr 18, 2000
Priority date
Expiry dateJun 1, 2015

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/828
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates generally to methods and compositions for targeting the vasculature of solid tumors using immunological- and growth factor-based reagents. In particular aspects, antibodies carrying diagnostic or therapeutic agents are targeted to the vasculature of solid tumor masses through recognition of tumor vasculature-associated antigens, such as, for example, through endoglin binding, or through the specific induction of endothelial cell surface antigens on vascular endothelial cells in solid tumors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.